Analysis Article • 13h
Have your own idea? Try our Stock Screener
Singaporean (SGX) Healthcare Sector Analysis
UpdatedAug 15, 2026
DataAggregated Company Financials
Companies30
- 7D-0.7%
- 3M-5.0%
- 1Y14.5%
- YTD-6.2%
The Healthcare is pretty flat in the last 7 days, but UltraGreen.ai has stood out, gaining 6.8%. The past year has been better, since the industry has gained 14% in that time. Earnings are forecast to grow by 24% annually.
Sector Valuation and Performance
Has the Singaporean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 15 Aug 2026 | S$12.4b | S$3.5b | S$369.2m | 18.7x | 33.6x | 3.6x |
| Mon, 13 Jul 2026 | S$12.7b | S$3.5b | S$356.4m | 20.7x | 35.6x | 3.7x |
| Wed, 10 Jun 2026 | S$11.7b | S$3.2b | S$342.2m | 18.9x | 34.1x | 3.6x |
| Fri, 08 May 2026 | S$12.0b | S$3.2b | S$348.3m | 17.1x | 34.3x | 3.7x |
| Sun, 05 Apr 2026 | S$11.6b | S$3.2b | S$351.5m | 15.8x | 33.1x | 3.6x |
| Tue, 03 Mar 2026 | S$10.3b | S$3.1b | S$314.2m | 16.9x | 32.6x | 3.3x |
| Thu, 29 Jan 2026 | S$10.1b | S$3.1b | S$295.8m | 14.8x | 34.1x | 3.3x |
| Sat, 27 Dec 2025 | S$9.8b | S$3.1b | S$295.6m | 15.4x | 33.1x | 3.2x |
| Mon, 24 Nov 2025 | S$9.4b | S$3.1b | S$294.9m | 15.4x | 32x | 3.1x |
| Wed, 22 Oct 2025 | S$9.5b | S$3.1b | S$305.3m | 16.3x | 31.2x | 3.1x |
| Fri, 19 Sep 2025 | S$9.3b | S$3.1b | S$307.3m | 15.6x | 30.2x | 3x |
| Sun, 17 Aug 2025 | S$9.3b | S$3.1b | S$388.7m | 13.9x | 24x | 3x |
| Tue, 15 Jul 2025 | S$8.8b | S$3.1b | S$373.6m | 12.5x | 23.7x | 2.9x |
| Thu, 12 Jun 2025 | S$8.7b | S$3.1b | S$372.9m | 12.1x | 23.4x | 2.8x |
| Sat, 10 May 2025 | S$8.6b | S$3.1b | S$367.8m | 12.6x | 23.4x | 2.8x |
| Mon, 07 Apr 2025 | S$9.0b | S$3.1b | S$373.3m | 12.5x | 24.1x | 2.9x |
| Wed, 05 Mar 2025 | S$9.1b | S$3.1b | S$358.7m | 13x | 25.3x | 2.9x |
| Fri, 31 Jan 2025 | S$8.7b | S$3.0b | S$351.3m | 16.5x | 24.6x | 2.9x |
| Sun, 29 Dec 2024 | S$8.7b | S$3.0b | S$350.2m | 16.6x | 25x | 2.9x |
| Tue, 26 Nov 2024 | S$8.8b | S$3.0b | S$350.1m | 16.6x | 25.1x | 3x |
| Thu, 24 Oct 2024 | S$8.7b | S$2.9b | S$359.4m | 16.4x | 24.3x | 3x |
| Sat, 21 Sep 2024 | S$8.6b | S$3.0b | S$364.4m | 16.1x | 23.7x | 2.9x |
| Mon, 19 Aug 2024 | S$8.4b | S$2.9b | S$344.6m | 16.8x | 24.4x | 2.9x |
| Wed, 17 Jul 2024 | S$8.9b | S$2.9b | S$360.9m | 18.7x | 24.6x | 3.1x |
| Fri, 14 Jun 2024 | S$8.6b | S$2.9b | S$364.4m | 17.1x | 23.6x | 3x |
| Sun, 12 May 2024 | S$8.6b | S$2.9b | S$365.1m | 15.8x | 23.5x | 3x |
| Tue, 09 Apr 2024 | S$8.5b | S$2.9b | S$357.8m | 16.3x | 23.8x | 3x |
| Thu, 07 Mar 2024 | S$8.2b | S$2.9b | S$412.0m | 14x | 20x | 2.8x |
| Sat, 03 Feb 2024 | S$8.9b | S$3.2b | S$438.2m | 15x | 20.3x | 2.8x |
| Mon, 01 Jan 2024 | S$9.4b | S$3.2b | S$441.7m | 15.8x | 21.3x | 3x |
| Wed, 29 Nov 2023 | S$12.3b | S$4.4b | S$579.4m | 15.5x | 21.3x | 2.8x |
| Fri, 27 Oct 2023 | S$11.7b | S$4.4b | S$597.8m | 15.6x | 19.6x | 2.7x |
| Sun, 24 Sep 2023 | S$12.4b | S$4.4b | S$598.5m | 16x | 20.8x | 2.8x |
| Tue, 22 Aug 2023 | S$12.7b | S$4.4b | S$648.6m | 16x | 19.6x | 2.9x |
Price to Earnings Ratio
19.6x
Current Industry PE
- Investors are optimistic on the Singaporean Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 33.2x which is higher than its 3-year average PE of 26.3x.
- The 3-year average PS ratio of 3.1x is lower than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 16% per year over the last three years,
- Revenues have also declined 7.9% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Singaporean Healthcare sector?
| SG Market | 0.75% | |
| Healthcare | -0.66% | |
| Medical Equipment | 3.70% | |
| Healthtech | 0% | 0 |
| Healthcare Services | -0.21% | |
| Pharma | -4.42% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 16.1%, which is higher than its past year's earnings growth of 4.3% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 49% over the next 5 years.
- This is better than its past earnings decline of 17% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 4.2% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ULG UltraGreen.ai | US$1.26 | 6.8% +US$88.2m | n/a | PE21.2x | |
| A50 Thomson Medical Group | S$0.054 | 1.9% +S$26.4m | 14.9% | PS3x | |
| AP4 Riverstone Holdings | S$0.84 | 1.2% +S$14.8m | 20.0% | PE18.7x | |
| 1H3 Clearbridge Health | S$0.002 | 100.0% +S$6.4m | -50.0% | PS1.3x | |
| QC7 Q & M Dental Group (Singapore) | S$0.56 | 0.9% +S$4.7m | 29.1% | PE56.4x |